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A fluorescent metabolite present in seven members of the genus Rhizopus was
isolated. This compound appeared green before spray treatment and purple after
spray treatment with p-anisaldehyde in visible light. Subsequent purification and
structural elucidation of the isolated compound yielded 1-[2,6,10,14-tetramethyl17-carbomethyl heptadecyl]-1-[2,6,10,14-tetramethyl-17-methanoyl heptadecyl]benzene.

A number of fluorescent metabolites were detected in seven members of the genus Rhizopus
by Thompson and Smalley (5). These metabolites were separated by thin-layer chromatography and analyzed by their chromatographic behavior and reaction to spray reagents. The data
obtained from these analyses, when compared
with those of known mycotoxins, did not reveal
the presence of any of the known mycotoxins.
This study describes the isolation, purification,
and structural elucidation of one fluorescent metabolite present in all seven fungi.
Species of Rhizopus used in this work were
obtained from the American Type Culture Collection (Rockville, Md.) and the Department of
National Health and Welfare (Ottawa, Ontario,
Canada). Stock cultures were maintained at 5°C
on slants of potato-dextrose agar enriched with
0.2% yeast extract. The cultural procedures employed were those previously described by van
Walbeek et al. (7). The fungi were grown in
mycological broth enriched with 0.5% yeast extract and with 15% sucrose plus 2% yeast extract
for 14 days at 27°C.
The extraction procedures described by Armbrecht et al. (1) were used to extract the secondary metabolites. The secondary metabolites
were separated by thin-layer chromatography
(5). The procedures of Steyn (4) and Scott et al.
(3) were employed to detect the presence of
nonfluorescent materials with chromatogenic reagents.
The chloroform extracts were spotted on
0.500-mm thin-layer chromatography plates
(Redi-Coat 5-8172, Aflasil, Supelco, Bellefonte,
Pa). Plates were developed with benzene-methanol-acetic acid (24:4:1, vol/vol/vol) and chloroform-methanol (99:1, vol/vol). The zone containing the metabolite was scraped from the
plates, eluted with methanol, and rechromatographed on thin-layer chromatography plates
for further purification. The zone was once again

scraped from the thin-layer chromatography
plates and eluted with methanol. Final purification was achieved by crystaization from petroleum ether-ethyl acetate. The melting point
of the metabolite was determined in sealed capillaries with an electrothermal melting point apparatus. Ultraviolet spectra in methanol were
taken with a Hitachi spectrophotometer (Arthur
Thomas Co.). The infrared spectra were measured with a Nicolet 7000 series dual-beam Fourier transform-infrared spectrophotometer. The
gas chromatograph-mass spectrograms were obtained on a Finnigan 4000 series instrument
equipped with a 2000 INCOS 2000 series data
system. Nuclear magnetic resonance spectra
were determined with a Varian model EM-390
MHz spectrometer. Liquid chromatograms were
obtained on a Waters model 204 liquid chromatograph equipped with a C-18 reversed-phase
column, ultraviolet detector, and integrator.
The Rf values x 100 of the metabolite developed with benzene-methanol-acetic acid and
with chloroform-methanol were 61 and 73, respectively. The fluorescent metabolite appeared
green before spray treatment and purple after
spray treatment with p-anisaldehyde in visible
light. The melting point of the metabolite ranged
from 125 to 128°C. The ultraviolet spectrum
showed Xmas at 210nm (zM.x 21,100 [Fig. 1]). As
shown in Fig. 2, the liquid chromatogram exhibited a single narrow peak at retention time of
0.69 min, which indicates a single compound.
The presence of a single compound in the data
from the liquid chromatogram was in agreement
with the results obtained from the thin-layer
chromotography plates. The nuclear magne#c
resonance spectrum (Fig. 3) exhibited a singlet
at 810 (phenol H), a multiplet at 82.7 (CH2H),
and a multiplet at 82.0 (CH3). The infrared spectrum showed characteristic absorption peaks
at 3,610 cm-' (M, OH), 1,230 cm-' (s, C-O),
and 730 to 790 cm-' (strong). Peaks in the re-
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gion of 1,500 to 2,000 cm-' exhibited an absorption pattern characteristic of an orthodisubstituted benzene (2). As shown in Fig. 4, the gas
chromatography-mass spectrometry data revealed alkyl fragments containing 22, 18, and 16
carbon atoms (spectrum no. 1,866, 1,843, and
1,678, respectively) and a disooctyl benzene frag-
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FIG. 1. Ultraviolet spectra of the metabolite
(
) and aflatoxin G2 ( -).

FIG. 2. Liquid chromatography of the fluorescent
metabolite.
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FIG. 3. Nuclear magnetic resonance spectrum of the fluorescent metabolite.
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FIG. 4. Gas chromatography mass spectrum of the fluorescent metabolite.
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FIG. 5. Structure of the fluorescent metabolite.
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